Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ElechtraPlatinum: Electrochemotherapy in Vulvar Cancer
NCT05395962Phase 2Recruiting
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Apr 2022
- Primary completion
- Apr 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carboplatin in vulvar cancer (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Local Progression-Free Survival at 5 years. Started Apr 2022; status: recruiting.
02
Drugs
carboplatin
03
Conditions
vulvar cancer
Beyond the preview
Go deeper on NCT05395962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05395962.